8-K 1 a04-10796_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  10549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  September 21, 2004

 

Enpath Medical, Inc.

(Exact name of registrant as specified in its charter)

 

Minnesota

(State or Other Jurisdiction of Incorporation)

 

 

 

0-19467

 

41-1533300

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

15301 Highway 55 West

 

 

Plymouth, Minnesota

 

55447

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

 

(763) 559-2613

(Registrant’s telephone number, including area code)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Section 8 – Other Events

 

Item 8.01 – Other Events

 

On September 21, 2004, Enpath Medical, Inc. issued a press release revising its guidance for the quarter ended September 30, 2004, and the remainder of 2004.  The press release also reported addition developments in the Company’s business.

 

A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K

 

Section 9 – Financial Statement and Exhibits

 

Item 9.01 – Financial Statement and Exhibits

 

(c) Exhibits

 

Exhibit 99.1                                    Press Release dated September 21, 2004.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

ENPATH MEDICAL, INC.

 

 

 

Dated:  September 21, 2004

By

Mark C. Kraus

 

 

 

Mark C. Kraus, President, Enpath Delivery
Systems

 

2